REVIEW
Accepted on 08 Sep 2025
eIF3b-Driven Autophagy and Wnt/β-Catenin Crosstalk: A Novel Regulatory Axis in Adriamycin Resistance of Breast Cancer
doi 10.3389/or.2025.1669457
- 237 views
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Advancement of Chemotherapy in Breast Cancer: Predictive Markers, Resistance Mechanism and Therapeutic Strategies
Advancement of Chemotherapy in Breast Cancer: Predictive Markers, Resistance Mechanism and Therapeutic Strategies
3,107
Total downloads
13k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
SYSTEMATIC REVIEW
Accepted on 29 Aug 2025
A Systematic Review of Progress toward Unlocking the Power of Epigenetics in Breast Cancer: Latest Updates and Perspectives
doi 10.3389/fphar.2025.1628165
- 378 views
ORIGINAL RESEARCH
Published on 16 Jul 2025
Utilization of dexrazoxane in patients treated with doxorubicin: a retrospective, propensity matched analysis of cardiac function and toxicity
doi 10.3389/fonc.2025.1621409
- 813 views
ORIGINAL RESEARCH
Published on 09 May 2025
Correlation analysis of pharmacokinetic parameters of docetaxel AUC and adverse reactions in breast cancer patients
doi 10.3389/fphar.2025.1563506
- 1,013 views
ORIGINAL RESEARCH
Published on 12 Mar 2025
Prediction of neoadjuvant chemotherapy efficacy and prognostic biomarker analysis in patients with triple-negative breast cancer
doi 10.3389/fphar.2025.1553831
- 1,314 views
ORIGINAL RESEARCH
Published on 24 Jan 2025
The association of systemic immune-inflammation index with incident breast cancer and all-cause mortality: evidence from a large population-based study
doi 10.3389/fimmu.2025.1528690
- 3,159 views
- 3 citations
HYPOTHESIS AND THEORY
Published on 06 Jan 2025
Clinical significance of lipid pathway-targeted therapy in breast cancer
doi 10.3389/fphar.2024.1514811
- 1,282 views
- 1 citation
ORIGINAL RESEARCH
Published on 01 Nov 2024
Identification and validation of mRNA profiles linked to ATP- induced cell death represent a novel prognostic model for breast cancer
doi 10.3389/fimmu.2024.1483498
- 1,827 views
- 1 citation
Published in
Frontiers in Oncology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Pharmacology
- 4.8 impact factor
- 8.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: